Company Overview and News
The Indian benchmark indices including the Sensex and the Nifty have turned red this Friday afternoon with the Nifty50 down 165 points and is trading at 11,069 while the Sensex has plunged 500 points at 36,621.
IOC PWQFY 500325 FEDA 532712 532832 531500 539437 535789 RCOM 532483 FEDS BJJQY GAILF 500570 BEL FEDERALBNK EICHERMOT RLNIY ASHOKLEY RAJESHEXPO BHQRY AXB RELCAPITAL 511072 JETAIRWAYS CANFINHOME FDBAY YYBKY 511196 530965 AKLD JSWSTEEL CNRYY 500182 AXBA DHFL BAJFINANCE GAILY KOTAKBANK MAX CANBK AKLS 506401 MXGQY IBREALEST 532939 500469 533150 500228 RELIANCE 532617 533273 KTKBANK 532810 532215 533106 DEEPAKNI 505200 500271 IDFCBANK 532461 OIL AXISBANK RIGD HEROMOTOCO 500477 TATAMOTORS 500034 500111 YESBANK RPOWER ECQRY KMBKY IDKQY 532648 AXBKY IBULHSGFIN PFC 532652 OBZIY GODREJPROP OBEROIRLTY PNJZY PNB HRTQY 500247 500049 TTM
Shares of JSW Steel today hit a life-high as the Competition Commission of India has found no adverse effect on competition from Bhushan deal. The stock hit a record high, rising as much as 2.5 per cent to Rs 427.55.
YESBANK 500470 TTST TATASTEEL TATLY 500228 BHUSANSTL 532648 YYBKY JSWSTEEL 500055
The Indian stock market have turned weak and is trading flat this Friday afternoon with the Nifty50 down 16 points and is trading at 11,217 while the Sensex is trading higher by 20 points at 37,141.
IOC 500325 JIPKY 532514 535789 IGL JUSTDIAL 532483 534816 SONATSOFTW 500696 GAILF BEL RLNIY SBAZ BHQRY AXB 533282 JETAIRWAYS YYBKY 530965 JSWSTEEL CNRYY AXBA BAJAJFINSV TATASTEEL TATLY 500180 GAILY CANBK 506401 BHRYY 533150 500228 RELIANCE 532617 HINDUNILVR 532978 533155 JUBLFOOD 532215 DEEPAKNI 532221 500470 535648 AXISBANK RIGD JBLWY INFRATEL HDFCBANK GRAVITA YESBANK IBN IDKQY 532648 JPASSOCIAT AXBKY 532532 IBULHSGFIN ICICIBANK GODREJPROP TTST HDB 532174 500049 JSTQY
It is a strong start for the Indian stock market this Friday morning with the Nifty50 up 89 points and is trading at 11,323 while the Sensex is trading higher by 294 points at 37,415.
523405 IOC RTI RLTAY 500325 82HP TCHQY PRMQY ASIANPAINT 532755 JUSTDIAL 532483 GAILF BEL JMFINANCIL RLNIY SBAZ BHQRY AXB 524804 532508 JETAIRWAYS YYBKY 530965 JSWSTEEL CNRYY TECHM AXBA TATASTEEL TATLY GAILY 500302 CANBK 506401 500188 HINDZINC 523367 500820 AUROPHARMA 533150 500228 RELIANCE 532617 HNDZY 532215 DEEPAKNI 500470 535648 532461 AXISBANK RIGD JSL YESBANK UBNC HINDALCO IBN 532648 PEL AXBKY HNDNF ICICIBANK GODREJPROP TTST PNJZY 532174 ARBQY 500366 PNB DCMSHRIRAM 500049 ROLTA JSTQY 500440
New Delhi : The Competition Commission has approved the acquisition of debt-ridden Essar Steel by a consortium of ArcelorMittal and Japan’s Nippon Steel & Sumitomo Metal Corporation.
New Delhi: The Competition Commission of India (CCI has approved the acquisition of debt-ridden Essar Steel by a consortium of ArcelorMittal and Japan’s Nippon Steel & Sumitomo Metal Corporation.
The Competition Commission has approved the acquisition of debt-ridden Essar Steel by a consortium of ArcelorMittal and Japan's Nippon Steel & Sumitomo Metal Corporation.
The Bombay High Court on Wednesday granted interim relief to the Adani group by restraining the Directorate of Revenue Intelligence (DRI) from giving effect to the letters rogatory (LRs) issued to several countries against three group companies in an alleged case of overvaluation of Indonesian coal imports in the past.
ANNRY ADANIENT 500228 INDIACEM 530005 512599 JSWSTEEL JSWENERGY 533148
The Indian stock market has turned negative this Wednesday afternoon with the Nifty50 down 28 points and is trading at 11,250 while the Sensex is trading lower by 82 points at 37,207.
MUTHOOTFIN 500325 532712 532832 533137 DEN RCOM SONATSOFTW 500179 GAILF BEL CLNDY RLNIY SBAZ BHQRY RELCAPITAL 532508 JETAIRWAYS JSWSTEEL 500182 TATASTEEL TATLY GAILY GLOBUSSPR COALINDIA IBREALEST 523367 533150 500228 RELIANCE 532617 533273 533398 533278 HCL-INSYS 532221 500470 RIGD HEROMOTOCO JSL 500111 UBNC 533104 OBZIY GODREJPROP TTST OBEROIRLTY DCMSHRIRAM HRTQY 500049
Shares of metal companies jumped after Reuters reported that the government is considering raising the import duty on steel to support rupee. Nifty metal index rose as much 2.1 per cent, its biggest gain in nearly a week
HNDNF 500470 HINDALCO TTST TATASTEEL TATLY 500228 500440 JSWSTEEL
The Indian benchmark indices continues to trade on a positive note this Wednesday afternoon with the Nifty50 up 21 points and is trading at 11,300 while the Sensex is trading higher by 53 points at 37,343.
HINDCOPPER KOHINOOR MUTHOOTFIN PGEL 500325 500228 RELIANCE 532617 HNDZY HFCL 533398 NAUKRI 532777 533137 HCL-INSYS DEN 532221 500470 SONATSOFTW RIGD 500179 JSL GAILF BEL RLNIY SBAZ BHQRY HINDALCO 532508 533581 513599 JETAIRWAYS JSWSTEEL 533104 512559 HNDNF 500183 TTST TATASTEEL TATLY GAILY DCMSHRIRAM 500049 GLOBUSSPR 500440 500188 HINDZINC 523367
The Indian benchmark indices have managed to open higher and is trading on a positive note this Wednesday morning with the Nifty50 up 22 points and is trading at 11,300 while the Sensex is trading higher by 84 points at 37,374.
RTI RLTAY PGEL 500325 82HP JISLJALEQS USHAMART 532121 SONATSOFTW 500179 BEL CLNDY RLNIY 500219 BHQRY 524804 533282 UHBTY JETAIRWAYS 532505 JSWSTEEL 512559 TATASTEEL TATLY GLOBUSSPR COALINDIA 500188 HINDZINC 523367 524715 HINDCOPPER KOHINOOR 517146 AUROPHARMA 500228 RELIANCE 532617 HNDZY 533278 HCL-INSYS 532221 500470 RIGD GRAVITA 570004 HINDALCO 533581 513599 533104 HNDNF TTST JISLDVREQS ARBQY SUNPHARMA 500366 DCMSHRIRAM 500049 UCOBANK ROLTA DENABANK 500440
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...